1. Home
  2. STRT vs TRDA Comparison

STRT vs TRDA Comparison

Compare STRT & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

N/A

Current Price

$65.23

Market Cap

241.4M

ML Signal

N/A

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$4.68

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STRT
TRDA
Founded
1908
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.4M
275.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
STRT
TRDA
Price
$65.23
$4.68
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
★ $84.00
$19.00
AVG Volume (30 Days)
49.5K
★ 384.9K
Earning Date
10-29-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 9.17
N/A
EPS
★ 1.19
N/A
Revenue
★ $439,195,000.00
$25,421,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.38
$156.96
P/E Ratio
$53.18
★ N/A
Revenue Growth
★ 5.24
N/A
52 Week Low
$57.01
$4.11
52 Week High
$93.00
$16.45

Technical Indicators

Market Signals
Indicator
STRT
TRDA
Relative Strength Index (RSI) 52.56 45.79
Support Level $59.35 $4.11
Resistance Level $84.30 $7.89
Average True Range (ATR) 2.10 0.47
MACD 0.71 0.09
Stochastic Oscillator 66.40 58.62

Price Performance

Historical Comparison
STRT
TRDA

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs automotive access company that designs and delivers safe, secure, and engineered access solutions for the automotive and mobility markets. Built on generations of access and security engineering expertise, partner closely with OEMs to create differentiated, system level access experiences for end consumers. Its product portfolio spans the access journey from Permission, enabling secure vehicle entry through advanced mechanical and electronic systems; to Motion, delivering effortless, reliable powered access that enhances everyday usability; and through to Hold, providing precision engineered latching solutions.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: